• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol-South Tyrol-Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

The role of activin signaling in small cell lung cancer

The role of activin signaling in small cell lung cancer

Balazs Dome (ORCID: 0000-0001-8799-8624)
  • Grant DOI 10.55776/I3522
  • Funding program Principal Investigator Projects International
  • Status ended
  • Start June 1, 2018
  • End December 31, 2021
  • Funding amount € 109,226

Bilaterale Ausschreibung: Ungarn

Disciplines

Clinical Medicine (50%); Medical-Theoretical Sciences, Pharmacy (50%)

Keywords

    Small Cell Lung Cancer, Activin-A

Abstract

Small cell lung cancer (SCLC) is an aggressive lung tumor prone to metastasize and with frequent relapse after initial response to chemotherapy. Activins are signaling molecules which regulate a number of important cell functions. Preliminary results from our collaborative group suggested that high activin A (ActA) levels in the blood of SCLC patients correlate with metastasis and shortened survival time. In our pilot studies, we also found that activin A (ActA) overexpression promotes lymphatic spread of human SCLC cells in mice. In the current project, we plan to investigate the exact biological role of ActA in the malignant behavior of human SCLC and, moreover, to determine the diagnostic and/or therapeutic significance of ActA in this aggressive lung tumor.

Research institution(s)
  • Medizinische Universität Wien - 100%
International project participants
  • Sandor Paku, Semmelweis University - Hungary

Research Output

  • 656 Citations
  • 54 Publications
Publications
  • 2021
    Title Clinical relevance of circulating activin A and follistatin in small cell lung cancer
    DOI 10.1016/j.lungcan.2021.09.008
    Type Journal Article
    Author Barany N
    Journal Lung Cancer
    Pages 128-135
    Link Publication
  • 2021
    Title Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer
    DOI 10.14288/1.0402439
    Type Other
    Author Lohinai Z
    Link Publication
  • 2023
    Title Additional file 3 of Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
    DOI 10.6084/m9.figshare.22605130.v1
    Type Other
    Author Flehberger D
    Link Publication
  • 2023
    Title Additional file 3 of Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
    DOI 10.6084/m9.figshare.22605130
    Type Other
    Author Flehberger D
    Link Publication
  • 2023
    Title Additional file 1 of Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
    DOI 10.6084/m9.figshare.22605124.v1
    Type Other
    Author Flehberger D
    Link Publication
  • 2023
    Title Additional file 1 of Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
    DOI 10.6084/m9.figshare.22605124
    Type Other
    Author Flehberger D
    Link Publication
  • 2023
    Title Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis.
    DOI 10.1111/1759-7714.15004
    Type Journal Article
    Author Mosleh B
    Journal Thoracic cancer
    Pages 2177-2186
  • 2023
    Title Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
    DOI 10.1080/2162402x.2023.2204746
    Type Journal Article
    Author Dora D
    Journal OncoImmunology
  • 2023
    Title Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair.
    DOI 10.1158/1078-0432.ccr-23-1795
    Type Journal Article
    Author Boettiger K
    Journal Clinical cancer research : an official journal of the American Association for Cancer Research
    Pages 4644-4659
  • 2023
    Title Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin.
    DOI 10.1186/s13046-022-02582-0
    Type Journal Article
    Author Flehberger D
    Journal Journal of experimental & clinical cancer research : CR
    Pages 27
  • 2022
    Title Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
    DOI 10.21203/rs.3.rs-2045206/v1
    Type Preprint
    Author Ries A
    Link Publication
  • 2022
    Title In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer
    DOI 10.1002/ctm2.1060
    Type Journal Article
    Author Szeitz B
    Journal Clinical and Translational Medicine
    Link Publication
  • 2022
    Title Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Immunotherapy Show Distinct Microbial Signatures and Metabolic Pathways According to Clinical Outcomes
    DOI 10.1101/2022.10.05.22280734
    Type Preprint
    Author Dora D
    Pages 2022.10.05.22280734
    Link Publication
  • 2022
    Title Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases
    DOI 10.1016/j.esmoop.2022.100741
    Type Journal Article
    Author Woldmar N
    Journal ESMO Open
    Pages 100741
    Link Publication
  • 2024
    Title Additional file 1 of C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
    DOI 10.6084/m9.figshare.25242192.v1
    Type Other
    Author Lang C
    Link Publication
  • 2024
    Title Additional file 2 of C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
    DOI 10.6084/m9.figshare.25242195
    Type Other
    Author Lang C
    Link Publication
  • 2024
    Title Additional file 3 of C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
    DOI 10.6084/m9.figshare.25242198
    Type Other
    Author Lang C
    Link Publication
  • 2024
    Title Additional file 3 of C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
    DOI 10.6084/m9.figshare.25242198.v1
    Type Other
    Author Lang C
    Link Publication
  • 2024
    Title Additional file 2 of C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
    DOI 10.6084/m9.figshare.25242195.v1
    Type Other
    Author Lang C
    Link Publication
  • 2024
    Title Additional file 1 of C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
    DOI 10.6084/m9.figshare.25242192
    Type Other
    Author Lang C
    Link Publication
  • 2024
    Title Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms.
    DOI 10.1007/s00262-024-03704-7
    Type Journal Article
    Author Ferencz B
    Journal Cancer immunology, immunotherapy : CII
    Pages 114
  • 2024
    Title HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program.
    DOI 10.1007/s00330-023-10379-8
    Type Journal Article
    Author Kerpel-Fronius A
    Journal European radiology
    Pages 3462-3470
  • 2023
    Title Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells.
    DOI 10.3390/cells12152006
    Type Journal Article
    Author Ries A
    Journal Cells
  • 2023
    Title Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer.
    DOI 10.1038/s41416-023-02219-9
    Type Journal Article
    Author Megyesfalvi Z
    Journal British journal of cancer
    Pages 1850-1861
  • 2023
    Title LA-ICP-MS analysis reveals differences in chemotherapeutic drug distribution in surgically resected pleural mesothelioma
    DOI 10.22541/au.167275573.37513553/v1
    Type Preprint
    Author Klikovits T
  • 2023
    Title Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions.
    DOI 10.1038/s41467-023-38058-8
    Type Journal Article
    Author Lohinai Z
    Journal Nature communications
    Pages 2673
  • 2020
    Title Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomas
    DOI 10.1002/ctm2.106
    Type Journal Article
    Author Kelemen O
    Journal Clinical and Translational Medicine
    Link Publication
  • 2020
    Title Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution
    DOI 10.1002/1878-0261.12741
    Type Journal Article
    Author Dora D
    Journal Molecular Oncology
    Pages 1947-1965
    Link Publication
  • 2020
    Title Current therapy of KRAS-mutant lung cancer
    DOI 10.1007/s10555-020-09903-9
    Type Journal Article
    Author Ghimessy A
    Journal Cancer and Metastasis Reviews
    Pages 1159-1177
    Link Publication
  • 2024
    Title C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer.
    DOI 10.1186/s12957-024-03315-7
    Type Journal Article
    Author Lang C
    Journal World journal of surgical oncology
    Pages 57
  • 2024
    Title Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer
    DOI 10.1186/s12943-024-01953-9
    Type Journal Article
    Author Ernhofer B
    Journal Molecular Cancer
  • 2024
    Title YB-1 regulates mesothelioma cell migration via snail but not EGFR, MMP1, EPHA5 or PARK2.
    DOI 10.1002/1878-0261.13367
    Type Journal Article
    Author Eder S
    Journal Molecular oncology
    Pages 815-831
  • 2018
    Title The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma
    DOI 10.1007/s00109-018-1725-7
    Type Journal Article
    Author Laszlo V
    Journal Journal of Molecular Medicine
    Pages 231-242
    Link Publication
  • 2021
    Title The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation
    DOI 10.21037/tlcr-20-754
    Type Journal Article
    Author Radeczky P
    Journal Translational Lung Cancer Research
    Pages 675-684
    Link Publication
  • 2021
    Title EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study
    DOI 10.21037/tlcr-20-814
    Type Journal Article
    Author Gieszer B
    Journal Translational Lung Cancer Research
    Pages 662-674
    Link Publication
  • 2021
    Title Apelin promotes blood and lymph vessel formation and the growth of melanoma lung metastasis
    DOI 10.1038/s41598-021-85162-0
    Type Journal Article
    Author Berta J
    Journal Scientific Reports
    Pages 5798
    Link Publication
  • 2021
    Title Molecular profiles of small cell lung cancer subtypes: Therapeutic implications
    DOI 10.1016/j.omto.2021.02.004
    Type Journal Article
    Author Schwendenwein A
    Journal Molecular Therapy - Oncolytics
    Pages 470-483
    Link Publication
  • 2021
    Title The landscape of small cell lung cancer metastases: Organ specificity and timing
    DOI 10.1111/1759-7714.13854
    Type Journal Article
    Author Megyesfalvi Z
    Journal Thoracic Cancer
    Pages 914-923
    Link Publication
  • 2021
    Title Allosteric and ATP-Competitive MEK-Inhibition in a Novel Spitzoid Melanoma Model with a RAF- and Phosphorylation-Independent Mutation
    DOI 10.3390/cancers13040829
    Type Journal Article
    Author Hegedüs L
    Journal Cancers
    Pages 829
    Link Publication
  • 2021
    Title Down-regulation of A20 promotes immune escape of lung adenocarcinomas
    DOI 10.1126/scitranslmed.abc3911
    Type Journal Article
    Author Breitenecker K
    Journal Science Translational Medicine
    Link Publication
  • 2021
    Title Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor
    DOI 10.3389/pore.2021.1609926
    Type Journal Article
    Author Radeczky P
    Journal Pathology & Oncology Research
    Pages 1609926
    Link Publication
  • 2021
    Title Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer
    DOI 10.3390/cancers13174489
    Type Journal Article
    Author Oo H
    Journal Cancers
    Pages 4489
    Link Publication
  • 2019
    Title Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases
    DOI 10.21037/tlcr.2019.11.30
    Type Journal Article
    Author Lohinai Z
    Journal Translational Lung Cancer Research
    Pages 938-950
    Link Publication
  • 2022
    Title Protein Expression of immune checkpoints STING and MHCII in small cell lung cancer
    DOI 10.1007/s00262-022-03270-w
    Type Journal Article
    Author Dora D
    Journal Cancer Immunology, Immunotherapy
    Pages 561-578
    Link Publication
  • 2022
    Title Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program
    DOI 10.1007/s00330-022-08589-7
    Type Journal Article
    Author Kerpel-Fronius A
    Journal European Radiology
    Pages 4457-4467
  • 2022
    Title Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and grow
    DOI 10.21037/tlcr-21-828
    Type Journal Article
    Author Kovacs I
    Journal Translational Lung Cancer Research
    Pages 0-0
    Link Publication
  • 2022
    Title Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis
    DOI 10.1016/j.lungcan.2022.05.010
    Type Journal Article
    Author Lang C
    Journal Lung Cancer
    Pages 40-46
    Link Publication
  • 2022
    Title Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study
    DOI 10.1002/path.5922
    Type Journal Article
    Author Megyesfalvi Z
    Journal The Journal of Pathology
    Pages 674-686
    Link Publication
  • 2023
    Title Laser ablation-inductively coupled plasma-mass spectrometry analysis reveals differences in chemotherapeutic drug distribution in surgically resected pleural mesothelioma.
    DOI 10.1111/bcp.15813
    Type Journal Article
    Author Klikovits T
    Journal British journal of clinical pharmacology
    Pages 3364-3374
  • 2023
    Title Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer
    DOI 10.3390/cancers15205091
    Type Journal Article
    Author Dora D
    Journal Cancers
  • 2022
    Title Clinical and prognostic implications of CD47 and PD-L1 expression in surgically resected small-cell lung cancer
    DOI 10.1016/j.esmoop.2022.100631
    Type Journal Article
    Author Lang C
    Journal ESMO Open
    Pages 100631
    Link Publication
  • 2021
    Title Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study
    DOI 10.21037/tlcr-20-1114
    Type Journal Article
    Author Brcic L
    Journal Translational Lung Cancer Research
    Pages 1594-1607
    Link Publication
  • 2021
    Title Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer
    DOI 10.3390/biology10060502
    Type Journal Article
    Author Dora D
    Journal Biology
    Pages 502
    Link Publication
  • 2019
    Title KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy
    DOI 10.3390/cancers11101514
    Type Journal Article
    Author Ghimessy Á
    Journal Cancers
    Pages 1514
    Link Publication

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF